patient exposes the operator to more radiation. Regarding conditions related to radiation exposure, 94% believe infertility is potentially related, 83% cataracts, 93% leukemia and lymphoma, 57% central nervous system tumors, 77% birth defects, and 4% diabetes. Regarding protection, 9% wear lead-lined glasses, 30% dosimeters, 99% thyroid shields, 0% lead gloves, 97% lead apron, 26% lead shield, and 0% nothing. Regarding fluoroscopy machine settings, 7% knew the machine used was set to continuous, 73% pulse, and 21% were unsure. 66% had awareness of the directional travel the machine routinely used. Regarding safety techniques, 99% knew decreasing time and 100% knew wearing protective materials were ways to decrease exposure. However, when asked about distance and exposure, only 55% answered correctly. Most respondents believe radiation safety is important (89%) and desire more formal education (64%).
INTRODUCTION AND OBJECTIVES: Although multiparametric MRI (mpMRI) is the most accurate tool in the detection of clinically significant Prostate Cancer (CsPCa), some limitations have reduced its use as a triage test. ExactVu is a real-time micro-ultrasound system capable of providing 300% higher resolution compared to conventional trans rectal ultrasound. Similarly to mpMRI in which PIRADS protocol has been developed to standardize the likelihood of PCa risk, a novel protocol of risk identification called PRI-MUS, is being developed to provide the same intended benefits for microultrasound. The aim of our study was to evaluate the performance of ExactVu in the detection of CsPCa.
METHODS: Patients with PCa diagnosed at fusion biopsy were imaged with ExactVu. CsPCa was defined as any Gleason Score !3þ4. ExactVu examination was considered as positive when PRI-MUS score was !3. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and area under the receiver operator characteristic (ROC) curve (AUC) were calculated. RESULTS: 57 patients out of 68 (84%) had a csPCa. A detailed list of clinical, radiological and pathological characteristics of patients is reported in table 1a. PRI-MUS score was correctly assessed in 57% of cases (table 1b) . Regarding the detection of CsPCa (Fig. 1a) , ExactVu's sensitivity, specificity, PPV, and NPV was 68%, 73%, 93%, and 31%, respectively and the AUC was 0.7 (95% CI 0.5-0.8). Detecting CsPCa in the transition/anterior zone (Fig. 1b) the sensitivity, specificity, PPV, and NPV was 45%, 66%, 83% and 25% respectively ant the AUC was 0.5 (95% CI 0.2-0.9). Accounting only the CsPCa located in the peripheral zone (Fig. 1c) , sensitivity, specificity, PPV, and NPV raised up to 74%, 75%, 94%, 33%, respectively with AUC 0.75 (95% CI 0.5-0.9).
CONCLUSIONS: ExactVu provides high resolution of the prostatic peripheral zone and could represent a step forward in the detection of CsPCa in a triage setting. There is increasing evidence that the integrity of sperm DNA may be associated with recurrent miscarriage and failure of implantation. The objective of this study was to determine the DNA quality of testicular versus ejaculated sperm and secondary outcomes for single and double strand breaks, with the use of the Comet assay. Vol. 201, No. 4S, Supplement, Monday, May 6, 2019 THE JOURNAL OF UROLOGY Ò e1081
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